Filing Details

Accession Number:
0001062993-21-005065
Form Type:
13D Filing
Publication Date:
2021-05-26 20:00:00
Filed By:
Saba Capital
Company:
Nuveen Global High Income Fund (NYSE:JGH)
Filing Date:
2021-05-27
SEC Url:
13D Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Saba Capital Management 0 1,485,792 0 1,485,792 1,485,792 6.41%
Boaz R. Weinstein 0 1,485,792 0 1,485,792 1,485,792 6.41%
Saba Capital Management GP 0 1,485,792 0 1,485,792 1,485,792 6.41%
Filing

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

 

 

SCHEDULE 13D/A

 

Under the Securities Exchange Act of 1934

(Amendment No. 6)*

 

Nuveen Global High Income Fund

(Name of Issuer)

 

Common Shares, $0.01 par value

(Title of Class of Securities)

 

67075G103

(CUSIP Number)

 

Saba Capital Management, L.P.

405 Lexington Avenue

58th Floor

New York, NY 10174

Attention: Michael D'Angelo

(212) 542-4635

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

 

May 25, 2021

(Date of Event Which Requires Filing of This Statement)

 

   

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule 13d-1(f) or Rule 13d-1(g), check the following box. [X]

(Page 1 of 7 Pages)

   

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No.  67075G103 SCHEDULE 13D/A Page 2 of 7 Pages

1

NAME OF REPORTING PERSON

Saba Capital Management, L.P.

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ☐

(b) ☐

3

SEC USE ONLY

4

SOURCE OF FUNDS

OO (see Item 3)

5

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

6

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH:

7

SOLE VOTING POWER

-0-

8

SHARED VOTING POWER

1,485,792

9

SOLE DISPOSITIVE POWER

-0-

10

SHARED DISPOSITIVE POWER

1,485,792

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON

1,485,792

12

CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

 

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

6.41%

14

TYPE OF REPORTING PERSON

PN; IA

The percentages used herein are calculated based upon 23,177,393 shares of common stock outstanding as of 12/31/20, as disclosed in the company's N-CSR filed 3/8/21

CUSIP No.  67075G103 SCHEDULE 13D/A Page 3 of 7 Pages

1

NAME OF REPORTING PERSON

Boaz R. Weinstein

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ☐

(b) ☐

3

SEC USE ONLY

4

SOURCE OF FUNDS

OO (see Item 3)

5

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

6

CITIZENSHIP OR PLACE OF ORGANIZATION

United States

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH:

7

SOLE VOTING POWER

-0-

8

SHARED VOTING POWER

1,485,792

9

SOLE DISPOSITIVE POWER

-0-

10

SHARED DISPOSITIVE POWER

1,485,792

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON

1,485,792

12

CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

 

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

6.41%

14

TYPE OF REPORTING PERSON

IN

The percentages used herein are calculated based upon 23,177,393 shares of common stock outstanding as of 12/31/20, as disclosed in the company's N-CSR filed 3/8/21

CUSIP No.  67075G103 SCHEDULE 13D/A Page 4 of 7 Pages

1

NAME OF REPORTING PERSON

Saba Capital Management GP, LLC

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ☐

(b) ☐

3

SEC USE ONLY

4

SOURCE OF FUNDS

OO (see Item 3)

5

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

6

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH:

7

SOLE VOTING POWER

-0-

8

SHARED VOTING POWER

1,485,792

9

SOLE DISPOSITIVE POWER

-0-

10

SHARED DISPOSITIVE POWER

1,485,792

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON

1,485,792

12

CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

 

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

6.41%

14

TYPE OF REPORTING PERSON

OO

The percentages used herein are calculated based upon 23,177,393 shares of common stock outstanding as of 12/31/20, as disclosed in the company's N-CSR filed 3/8/21

CUSIP No.  67075G103 SCHEDULE 13D/A Page 5 of 7 Pages

Item 1.

SECURITY AND ISSUER

 

 

 

This Amendment No. 6 amends and supplements the statement on Schedule 13D filed with the SEC on 12/1/20, as amended by Amendment No. 1 filed 12/21/20, Amendment No. 2 filed 1/19/21, Amendment No. 3 filed 1/19/21, Amendment No. 4 filed 4/8/21, and Amendment No. 5 filed 4/27/21; with respect to the common shares of Nuveen Global High Income Fund.  This Amendment No. 6 amends Items 3 and 5 as set forth below.

 

 

Item 3.

SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION

 

 

 

Funds for the purchase of the Common Shares were derived from the subscription proceeds from investors and the capital appreciation thereon and margin account borrowings made in the ordinary course of business.  In such instances, the positions held in the margin accounts are pledged as collateral security for the repayment of debit balances in the account, which may exist from time to time.  Since other securities are held in the margin accounts, it is not possible to determine the amounts, if any, of margin used to purchase the Common Shares reported herein. A total of approximately $20,919,149 was paid to acquire the Common Shares reported herein.


Item 5.

INTEREST IN SECURITIES OF THE ISSUER

 

 

(a)

See rows (11) and (13) of the cover pages to this Schedule 13D/A for the aggregate number of Common Shares and percentages of the Common Shares beneficially owned by each of the Reporting Persons.  The percentages used herein are calculated based upon 23,177,393 shares of common stock outstanding as of 12/31/20, as disclosed in the company's N-CSR filed 3/8/21.

 

 

(b)

See rows (7) through (10) of the cover pages to this Schedule 13D/A for the number of Common Shares as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition.

 

 

(c)

The transactions in the Common Shares effected since the Schedule 13D/A filing on 4/27/21 by the Reporting Persons, which were all in the open market, are set forth in Schedule A, and are incorporated herein by reference

 

 

(d)

The funds and accounts advised by Saba Capital have the right to receive the dividends from and proceeds of sales from the Common Shares.

 

 

(e)

Not applicable.

 

 

CUSIP No.  67075G103 SCHEDULE 13D/A Page 6 of 7 Pages

SIGNATURES

After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

Date:  May 27, 2021

 

SABA CAPITAL MANAGEMENT, L.P.

By:  /s/ Michael D'Angelo

 

Name:  Michael D'Angelo

Title:    Chief Compliance Officer

 

 

 

 

 

SABA CAPITAL MANAGEMENT GP, LLC

By:  /s/ Michael D'Angelo

Name:  Michael D'Angelo

Title:    Authorized Signatory

 

 

 

 

 

BOAZ R. WEINSTEIN

By:  /s/ Michael D'Angelo

 

Name:  Michael D'Angelo

 

Title:    Attorney-in-fact*

   

* Pursuant to a power of attorney dated as of November 16, 2015, which is incorporated herein by reference to Exhibit 2 to the Schedule 13G filed by the Reporting Persons on December 28, 2015, accession number: 0001062993-15-006823

 


CUSIP No.  67075G103 SCHEDULE 13D/A Page 7 of 7 Pages

This Schedule sets forth information with respect to each purchase and sale of Common Shares which were effectuated by Saba Capital since the filing of Amendment No. 5 on 4/27/21. All transactions were effectuated in the open market through a broker.

Trade Date   Buy/Sell   Shares   Price
4/27/2021   Sell   15,900  

15.79

4/28/2021   Sell   11,627   15.75
4/29/2021    Sell   14,804   15.80
4/30/2021   Sell   1,475    15.80 
5/3/2021   Sell   13,426   15.89
5/4/2021   Sell   12,268   15.84
5/5/2021   Sell   11,877   15.88
5/6/2021   Sell   4,010   15.91
5/7/2021   Sell   7,286    15.90
5/10/2021   Sell   11,109   15.91
5/11/2021   Sell   2,519   15.86
5/12/2021   Sell   6,673   15.82
5/13/2021   Sell   12,695   15.70
5/14/2021   Sell   5,793   15.74
5/17/2021   Sell   10,818   15.73
5/18/2021   Sell   27,983   15.69
5/19/2021   Sell   25,853   15.72
5/20/2021   Sell   500   15.73
5/21/2021   Sell   97   15.77
5/24/2021   Sell   19,344   15.76
5/25/2021   Sell   24,293   15.81
5/26/2021   Sell   10,620   15.87